| Ticker Details |
Atai Life Sciences N.V.
ATA Inc is a computer-based testing service provider. The company offers testing systems such as test development, test delivery, and data management. It also provides test-based training, education programs, and test preparation courses to individuals.
|
| IPO Date: |
June 18, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.45B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 4.19%
|
| Avg Daily Range (30 D): |
$0.14 | 3.15%
|
| Avg Daily Range (90 D): |
$0.14 | 3.37%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.9M |
| Avg Daily Volume (30 D): |
4.54M |
| Avg Daily Volume (90 D): |
4.85M |
| Trade Size |
| Avg Trade Size (Sh.): |
215 |
| Avg Trade Size (Sh.) (30 D): |
173 |
| Avg Trade Size (Sh.) (90 D): |
189 |
| Institutional Trades |
| Total Institutional Trades: |
338 |
| Avg Institutional Trade: |
$1.51M |
| Avg Institutional Trade (30 D): |
$1.31M |
| Avg Institutional Trade (90 D): |
$1.79M |
| Avg Institutional Trade Volume: |
.36M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.69M |
| Avg Closing Trade (30 D): |
$1.43M |
| Avg Closing Trade (90 D): |
$2.02M |
| Avg Closing Volume: |
442.11K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.81
|
$-.28
|
$-.14
|
|
Diluted EPS
|
$-.81
|
$-.28
|
$-.14
|
|
Revenue
|
$3.02M
|
$.75M
|
$.72M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-154.3M
|
$-61.1M
|
$-27.75M
|
|
Operating Income / Loss
|
$-104.34M
|
$-28.44M
|
$-25.27M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-14.45M
|
$-31.07M
|
$3.45M
|
|
PE Ratio
|
|
|
|
|
|
|
